Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder (Q64252273)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

3 references

11 October 2020

24 August 2022

10 October 2022

Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

main subject

resveratrol

0 references

autism spectrum disorder

1 reference

1 reference

11 October 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Michele Malaguarnera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Richard E Frye

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

author name string

Renata Rizzo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Giovanni Tabbì

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Jean Bastin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

language of work or name

English

0 references

publication date

16 April 2019

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

11 October 2020

24 August 2022

10 October 2022

International Journal of Molecular Sciences

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

11 October 2020

24 August 2022

10 October 2022

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

4 May 2020

page(s)

1878

0 references

copyright license

3 references

11 October 2020

24 August 2022

10 October 2022

0 references

Differential effects of fatty acyl coenzyme A derivatives on citrate synthase and glutamate dehydrogenase

1 reference

12 December 2020

Inhibitory effect of 3-hydroxyacyl-CoAs and other long-chain fatty acidβ-oxidation intermediates on mitochondrial oxidative phosphorylation

1 reference

12 December 2020

Encephalitis and encephalopathy associated with an influenza epidemic in Japan

1 reference

12 December 2020

Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate

1 reference

12 December 2020

Peroxisome proliferator-activated receptor alpha target genes

1 reference

12 December 2020

Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase

1 reference

12 December 2020

Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects

1 reference

12 December 2020

Relative carnitine deficiency in autism

1 reference

12 December 2020

Metabolic control through the PGC-1 family of transcription coactivators

1 reference

12 December 2020

Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.

1 reference

12 December 2020

Parental report of the early development of children with regressive autism: the delays-plus-regression phenotype

1 reference

12 December 2020

Disorders of carnitine transport and the carnitine cycle

1 reference

12 December 2020

Therapeutic potential of resveratrol: the in vivo evidence

1 reference

12 December 2020

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

1 reference

12 December 2020

Pioglitazone as adjunctive therapy in adolescents with type 1 diabetes

1 reference

12 December 2020

Effect of pioglitazone treatment on behavioral symptoms in autistic children

1 reference

12 December 2020

PPARδ, but not PPARα, activates PGC-1α gene transcription in muscle

1 reference

12 December 2020

Pioglitazone as a therapeutic agent in autistic spectrum disorder

1 reference

12 December 2020

Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy

1 reference

12 December 2020

Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components

1 reference

12 December 2020

Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism.

1 reference

12 December 2020

Fat and beyond: the diverse biology of PPARgamma

1 reference

12 December 2020

PPARs in Neuroinflammation

1 reference

12 December 2020

Bezafibrate for an inborn mitochondrial beta-oxidation defect.

1 reference

12 December 2020

PPARdelta in humans: genetic and pharmacological evidence for a significant metabolic function

1 reference

12 December 2020

Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism.

1 reference

12 December 2020

Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta

1 reference

12 December 2020

Regulation of cellular metabolism by protein lysine acetylation

1 reference

12 December 2020

Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders

1 reference

12 December 2020

Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.

1 reference

12 December 2020

Altered T cell responses in children with autism

1 reference

12 December 2020

Mitochondrial dysfunction in autism

1 reference

12 December 2020

Clinical trials of resveratrol

1 reference

12 December 2020

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis

1 reference

12 December 2020

Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts

1 reference

12 December 2020

Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia

1 reference

12 December 2020

Bezafibrate upregulates carnitine palmitoyltransferase II expression and promotes mitochondrial energy crisis dissipation in fibroblasts of patients with influenza-associated encephalopathy

1 reference

12 December 2020

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures

1 reference

12 December 2020

Non-invasive evaluation of buccal respiratory chain enzyme dysfunction in mitochondrial disease: comparison with studies in muscle biopsy

1 reference

12 December 2020

Recent advances in the study on resveratrol

1 reference

12 December 2020

A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism

1 reference

12 December 2020

Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder

1 reference

12 December 2020

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence

1 reference

12 December 2020

Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3.

1 reference

12 December 2020

Alterations in the endocannabinoid system in the rat valproic acid model of autism.

1 reference

12 December 2020

Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability.

1 reference

12 December 2020

Regulation of mitochondrial fatty acid β-oxidation in human: what can we learn from inborn fatty acid β-oxidation deficiencies?

1 reference

12 December 2020

Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain

1 reference

12 December 2020

Role of the peroxisome proliferator-activated receptors (PPAR)-α, β/δ and γ triad in regulation of reactive oxygen species signaling in brain

1 reference

12 December 2020

Immune dysregulation in autism spectrum disorder

1 reference

12 December 2020

Mitochondrial dysfunction in autism

1 reference

12 December 2020

Regulation of energy metabolism by long-chain fatty acids

1 reference

12 December 2020

Overweight and obesity: prevalence and correlates in a large clinical sample of children with autism spectrum disorder

1 reference

12 December 2020

Mitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation

1 reference

12 December 2020

Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review

1 reference

12 December 2020

Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging

1 reference

12 December 2020

Deficits in bioenergetics and impaired immune response in granulocytes from children with autism

1 reference

12 December 2020

Fatty acids in energy metabolism of the central nervous system

1 reference

12 December 2020

Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts

1 reference

12 December 2020

Integrated physiology and systems biology of PPARα

1 reference

12 December 2020

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review

1 reference

12 December 2020

Resveratrol prevents social deficits in animal model of autism induced by valproic acid.

1 reference

12 December 2020

Neurodevelopmental profiles of children with very long chain acyl-CoA dehydrogenase deficiency diagnosed by newborn screening.

1 reference

12 December 2020

A single dose of PPARγ agonist pioglitazone reduces cortical oxidative damage and microglial reaction following lateral fluid percussion brain injury in rats

1 reference

12 December 2020

The pharmacology of resveratrol in animals and humans

1 reference

12 December 2020

Impact of fatty acid oxidation disorders in child neurology: from Reye syndrome to Pandora's box

1 reference

12 December 2020

Maternal PPARG Pro12Ala polymorphism is associated with infant's neurodevelopmental outcomes at 18 months of age.

1 reference

12 December 2020

Inherited metabolic disorders in Turkish patients with autism spectrum disorders

1 reference

12 December 2020

Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice

1 reference

12 December 2020

A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.

1 reference

12 December 2020

CSF N-glycan profile reveals sialylation deficiency in a patient with GM2 gangliosidosis presenting as childhood disintegrative disorder

1 reference

12 December 2020

The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders

1 reference

12 December 2020

Neuropsychological Development in Patients with Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency.

1 reference

12 December 2020

Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies

1 reference

12 December 2020

PPARβ/δ and lipid metabolism in the heart.

1 reference

12 December 2020

Carnitine transport and fatty acid oxidation

1 reference

12 December 2020

Inborn Errors of Long-Chain Fatty Acid β-Oxidation Link Neural Stem Cell Self-Renewal to Autism.

1 reference

12 December 2020

Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease

1 reference

12 December 2020

PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease

1 reference

12 December 2020

Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders

1 reference

12 December 2020

Efficacy of bezafibrate on fibroblasts of glutaric acidemia type II patients evaluated using an in vitro probe acylcarnitine assay.

1 reference

12 December 2020

Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ.

1 reference

12 December 2020

Resveratrol treatment attenuates chemokine receptor expression in the BTBR T+tf/J mouse model of autism

1 reference

12 December 2020

Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism.

1 reference

12 December 2020

Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines.

1 reference

12 December 2020

Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation

1 reference

12 December 2020

Autism in patients with propionic acidemia.

1 reference

12 December 2020

Histone Acetylome-wide Association Study of Autism Spectrum Disorder.

1 reference

12 December 2020

PPAR agonists, - Could tissue targeting pave the way?

1 reference

12 December 2020

Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing Process

1 reference

12 December 2020

Autoimmunity, Autoantibodies, and Autism Spectrum Disorder

1 reference

12 December 2020

Developmental regulation and localization of carnitine palmitoyltransferases (CPTs) in rat brain.

1 reference

12 December 2020

The mechanism of neuroprotective action of natural compounds

1 reference

12 December 2020

Mitochondrial dysfunction in Autism Spectrum Disorder: clinical features and perspectives

1 reference

12 December 2020

Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms.

1 reference

12 December 2020

Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder.

1 reference

12 December 2020

A Fatty Acid Oxidation-Dependent Metabolic Shift Regulates Adult Neural Stem Cell Activity

1 reference

12 December 2020

Genetics and epigenetics of autism: A Review

1 reference

12 December 2020

Mitochondrial Targeted Therapies: Where Do We Stand in Mental Disorders?

1 reference

12 December 2020

The impact of cellular metabolism on chromatin dynamics and epigenetics

1 reference

12 December 2020

Mitochondrial Etiology of Neuropsychiatric Disorders.

1 reference

12 December 2020

Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

1 reference

12 December 2020

Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism.

1 reference

12 December 2020

Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders.

1 reference

12 December 2020

Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA.

1 reference

12 December 2020

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

1 reference

12 December 2020

Resveratrol attenuates pro-inflammatory cytokines and activation of JAK1-STAT3 in BTBR T+ Itpr3tf/J autistic mice.

1 reference

12 December 2020

Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014.

1 reference

12 December 2020

Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial

1 reference

12 December 2020

Resveratrol Prevents Cellular and Behavioral Sensory Alterations in the Animal Model of Autism Induced by Valproic Acid.

1 reference

12 December 2020

Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder

1 reference

12 December 2020

Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents

1 reference

12 December 2020

Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERβ activation

1 reference

12 December 2020

Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms

1 reference

12 December 2020

Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses

1 reference

12 December 2020

Next generation sequencing of RNA reveals novel targets of resveratrol with possible implications for Canavan disease

1 reference

12 December 2020

A Subset of Patients With Autism Spectrum Disorders Show a Distinctive Metabolic Profile by Dried Blood Spot Analyses

1 reference

12 December 2020

Acetyl-CoA synthetase 3 promotes bladder cancer cell growth under metabolic stress

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1038/S41389-020-0230-3

6 January 2024

Identifiers

DOI

10.3390/IJMS20081878

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30995737%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

PubMed publication ID

30995737

1 reference